Literature DB >> 11742727

The effects of N-methyl-D-aspartate antagonist 2-amino-7-phosphonoheptanoic acid microinfusions into the adult male rat substantia nigra pars reticulata are site-specific.

J Velísková1, S Liptáková, S Hussain.   

Abstract

We examined the effects of regional infusions of 2-amino-7-phosphonoheptanoic acid (AP7) into the substantia nigra pars reticulata (SNR) in adult male rats on flurothyl-induced clonic seizures. AP7 infusions in the SNR had dose- and region-specific effects. In the SNR(anterior), both doses of AP7 (0.1 and 5 nmol) produced an anticonvulsant effect. In the SNR(posterior), the lower dose (0.1 nmol) did not influence the seizure threshold whereas the higher dose (5 nmol) of AP7 had a proconvulsant effect. The data indicate that there are two distinct regions within the SNR which differentially respond to pharmacological manipulations of the glutamatergic system. The region-specific effects in the SNR may provide an explanation for the previous conflicting reports regarding infusions of N-methyl-D-aspartate antagonists into this structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742727     DOI: 10.1016/s0304-3940(01)02379-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Metabolic environment in substantia nigra reticulata is critical for the expression and control of hypoglycemia-induced seizures.

Authors:  Libor Velísek; Jana Velísková; Ondrej Chudomel; Ka-Lai Poon; Kimberly Robeson; Barbara Marshall; Archana Sharma; Solomon L Moshé
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

2.  Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages.

Authors:  Jana Velísková; Alexandra M Miller; Magda L Nunes; Lucy L Brown
Journal:  Neurobiol Dis       Date:  2005-06-13       Impact factor: 5.996

3.  Update on the role of substantia nigra pars reticulata in the regulation of seizures.

Authors:  Jana Velísková; Solomon L Moshé
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.